3,4-dihydroxyphenylacetone

3'',4''-Dihydroxyphenylacetone (Item No. 19522) is an analytical reference standard. It is a minor metabolite of 3,4-MDEA (Item Nos. 14085 | 15689), MDMA, and α-methyldopa produced by oxidative deamination. This product is intended for forensic and research applications.

3',4'-Dihydroxypropiophenone, also known as DOPA, is a metabolite of dopamine, which is produced in the brain and kidneys. DOPA is a precursor to the synthesis of melanin, which is found in skin cells. Glutamate dehydrogenase converts DOPA to 3-methoxytyramine, which can be detected chromatographically in urine samples. Examining a urine sample for DOPA testing can be used to diagnose Parkinson's disease. DOPA may also be detected in plasma in patients with bacterial and urinary tract infections

Thick Yellow Oil

A metabolite of racemic 3,4-methylenedioxyethylamphetamine.

3',4'-Dihydroxyphenylacetone , MDMA, and α-methyldopa produced by oxidative deamination. This product is intended for forensic and research applications.

3,4-dihydroxylphenylacetaldehyde (DHPAA) synthase catalyzes a complicated decarboxylation-deamination process of α-methyl dopa (AMD), leading to the production of 3,4-dihydroxyphenylacetone.

ChEBI: 3,4-Dihydroxyphenylacetone is an alkylbenzene.

[1] H. K. LIM  R. L F. In vivo and in vitro metabolism of 3,4-(methylenedioxy)methamphetamine in the rat: identification of metabolites using an ion trap detector[J]. Chemical Research in Toxicology, 1988, 1 6: 370-378. DOI: 10.1021/tx00006a008
[2] H K ENSSLIN. Metabolism of racemic 3,4-methylenedioxyethylamphetamine in humans. Isolation, identification, quantification, and synthesis of urinary metabolites.[J]. Drug Metabolism and Disposition, 1996, 24 8: 813-820.
[3] MARIARITA BERTOLDI. Reaction of Dopa Decarboxylase with α-Methyldopa Leads to an Oxidative Deamination Producing 3,4-Dihydroxyphenylacetone, an Active Site Directed Affinity Label[J]. Biochemistry Biochemistry, 1998, 37 18: 6552-6561. DOI: 10.1021/bi9718898